Bernard Fromenty

15.8k citations
170 papers · 13.2k · 5 hit papers · h-index 62

Impact in

  • Pharmacology top 0.02%
    • Drug-Induced Hepatotoxicity and Protection
    • Pharmacogenetics and Drug Metabolism
  • Epidemiology top 0.5%
    • Liver Disease Diagnosis and Treatment

Papers in

    • Drug-Induced Hepatotoxicity and Protection 78
    • Pharmacogenetics and Drug Metabolism 9
    • Liver Disease Diagnosis and Treatment 33

Bernard Fromenty

167 papers receiving 12.6k citations

Bernard Fromenty's Hit Papers

Mitochondrial alterations in fatty liver diseases 2022 · 299 citations
2990+10+20Years since publication200400600

Peers

Bernard Fromenty
Comparison fields: 5 of 127
  • Pharmacology 4.2k
  • Epidemiology 3.7k
  • Hepatology 732
  • Pathology and Forensic Medicine 875
  • Molecular Biology 2.7k
Replace Dominique Pessayre with:
Dominique Pessayre France
Folkert Kuipers Netherlands
Philippe Lettéron France
Makoto Makishima Japan
Mitchell R. McGill United States
Han J. Moshage Netherlands
Toshifumi Aoyama Japan
Ariel E. Feldstein United States
Giuseppe Poli Italy
John Y.L. Chiang United States
Bernard Fromenty relative to Dominique Pessayre France Dominique Pessayre's profile →
Citations per field
00.5×2×3.2×
Dominique Pessayre · 1×
Citations per year

Countries citing papers authored by Bernard Fromenty

Since Specialization
Citations

This map shows the geographic impact of Bernard Fromenty's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bernard Fromenty with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bernard Fromenty more than expected).

Fields of papers citing papers by Bernard Fromenty

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bernard Fromenty. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bernard Fromenty. The network helps show where Bernard Fromenty may publish in the future.

Co-authors

The 25 scholars most cited alongside Bernard Fromenty, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Bernard Fromenty Line = papers co-authored together Bernard Fromenty links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 170 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Mitochondrial dysfunction in NASH: Causes, consequences and possible means to prevent it
Hit paper breakdown →
2006645
2
Inhibition of mitochondrial beta-oxidation as a mechanism of hepatotoxicity
Hit paper breakdown →
1995558
3
Mitochondrial adaptations and dysfunctions in nonalcoholic fatty liver disease
Hit paper breakdown →
2013517
4
Drug-induced toxicity on mitochondria and lipid metabolism: Mechanistic diversity and deleterious consequences for the liver
Hit paper breakdown →
2010451
5 2005375
6 1998339
7 2001330
8
Mitochondrial alterations in fatty liver diseases
Hit paper breakdown →
2022299
9 2008262
10 2002250
11 1996243
12 2011240
13 2004238
14 2011237
15 1999232
16 1997226
17 1990216
18 2016210
19 2001203
20 2015199

About Bernard Fromenty

Bernard Fromenty is a scholar working on Pharmacology, Epidemiology, Molecular Biology, Pathology and Forensic Medicine and Health, Toxicology and Mutagenesis, having authored 170 papers that have together received 13.2k indexed citations. Recurring topics across this work include Drug-Induced Hepatotoxicity and Protection (78 papers), Mitochondrial Function and Pathology (39 papers), Liver Disease Diagnosis and Treatment (33 papers), Alcohol Consumption and Health Effects (12 papers), Pharmacogenetics and Drug Metabolism (9 papers), HIV-related health complications and treatments (6 papers), Effects and risks of endocrine disrupting chemicals (5 papers) and HIV/AIDS drug development and treatment (5 papers). The work is most often cited by research in Pharmacology (4.2k citations), Epidemiology (3.7k citations), Hepatology (732 citations), Pathology and Forensic Medicine (875 citations) and Molecular Biology (2.7k citations). Bernard Fromenty has collaborated with scholars based in France, United States and United Kingdom. Frequent co-authors include Dominique Pessayre, Abdellah Mansouri, Karima Begriche, Alain Berson, Marie‐Anne Robin, Philippe Lettéron, Julie Massart, Anissa Igoudjil, Gilles Labbe and Claude Degott. Their work appears in journals such as Journal of Hepatology, Journal of Pharmacology and Experimental Therapeutics, Hepatology, Gastroenterology and Biochemical Pharmacology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact